ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer
ENTPD1/CD39 作为预测新诊断卵巢癌患者对 gemogenovatucel-T 维持治疗反应的标志物
期刊:
影响因子:
doi:10.1038/s43856-022-00163-y
Rocconi, Rodney P; Stanbery, Laura; Tang, Min; Madeira da Silva, Luciana; Walter, Adam; Monk, Bradley J; Herzog, Thomas J; Coleman, Robert L; Manning, Luisa; Wallraven, Gladice; Horvath, Staci; Bognar, Ernest; Senzer, Neil; Brun, Scott; Nemunaitis, John